FAP expression was higher in cancers of the bile duct, bladder, colon, esophagus, stomach, lung, oropharynx, ovary, and pancreas; average in breast and uterus cancer; and liver, prostate, and renal cell cancer showed only low FAP expression. This evidence concerns the gene FAP and uterine cancer.